Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment
Cancer Research, 08/04/09
Schrage YM et al. – Using kinome profiling, the authors found the Src pathway to be active in chondrosarcoma. Moreover, the authors showed in vitro that the inhibitor of the Src pathway, dasatinib, may provide a potential therapeutic benefit for chondrosarcoma patients who are not eligible for surgery.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Hip Geometry Variation is Associated With Bone Mineralization Pathway Gene Variants: The Framingham Study
Journal of Bone and Mineral Research, 11/13/09
Bone signaling pathways and treatment of osteoporosis
Expert Review of Endocrinology & Metabolism, 11/10/09
CDP/Cut is an Osteoblastic Co-Activator of the Vitamin D Receptor (VDR)
Journal of Bone and Mineral Research, 11/17/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/25/09
Endoprosthetic proximal femur replacement: Metastatic versus primary tumors
Surgical Oncology, 11/05/09
Survival in high-grade osteosarcoma: improvement over 21 years at a single institution
Annals of Oncology, 11/16/09
Article Search
Sponsor


See Latest Articles


